CN Patent

CN114286669A — 去甲肾上腺素的输注剂型

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2022-04-05 · 4y expired

What this patent protects

本发明提供去甲肾上腺素的即用型稳定水性剂型，其包含去甲肾上腺素或其医药学上可接受的盐的水性溶液、一种或多种亚硫酸盐抗氧化剂和离子螯合剂。本发明还提供填充有去甲肾上腺素或其医药学上可接受的盐的水性溶液的输注容器，其中所述溶液能够长期保持稳定且能够通过高压处理来最终灭菌。

USPTO Abstract

本发明提供去甲肾上腺素的即用型稳定水性剂型，其包含去甲肾上腺素或其医药学上可接受的盐的水性溶液、一种或多种亚硫酸盐抗氧化剂和离子螯合剂。本发明还提供填充有去甲肾上腺素或其医药学上可接受的盐的水性溶液的输注容器，其中所述溶液能够长期保持稳定且能够通过高压处理来最终灭菌。

Drugs covered by this patent

Patent Metadata

Patent number
CN114286669A
Jurisdiction
CN
Classification
—
Expires
2022-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.